Merit Medical Systems reported second-quarter results that exceeded analyst expectations and raised its full-year outlook. Revenue rose 9.5% year on year to $418.8 million, beating the consensus estimate of $405.3 million, while adjusted earnings per share of $1.19 came in 24% above the $0.96 forecast. The company lifted its full-year revenue guidance to $1.64 billion at the midpoint, up from $1.62 billion, and raised its adjusted EPS guidance to $4.30, a 5.4% increase. Organic revenue grew 9% year on year, and the adjusted operating margin improved to 14.4% from 12.3% a year earlier. Shares rose 5.1% to $87.73 following the announcement.
Merit Medical Systems IncBeat Q2 estimates and raised full-year guidance, driving shares up 5.1%